These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 14769003

  • 1. The HIV-1 Tat transactivator protein: a therapeutic target?
    Fulcher AJ, Jans DA.
    IUBMB Life; 2003 Dec; 55(12):669-80. PubMed ID: 14769003
    [Abstract] [Full Text] [Related]

  • 2. Regulation of expression of human immunodeficiency virus.
    Pavlakis GN, Felber BK.
    New Biol; 1990 Jan; 2(1):20-31. PubMed ID: 2078551
    [Abstract] [Full Text] [Related]

  • 3. RNA-sequence-mediated gene regulation in HIV-1.
    Cullen BR.
    Infect Agents Dis; 1994 Jan; 3(2-3):68-76. PubMed ID: 7812657
    [Abstract] [Full Text] [Related]

  • 4. [RNA ligands for HIV proteins].
    Iwai S.
    Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1430-7. PubMed ID: 7568944
    [No Abstract] [Full Text] [Related]

  • 5. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA.
    Rana TM, Jeang KT.
    Arch Biochem Biophys; 1999 May 15; 365(2):175-85. PubMed ID: 10328810
    [Abstract] [Full Text] [Related]

  • 6. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
    Mei HY, Cui M, Heldsinger A, Lemrow SM, Loo JA, Sannes-Lowery KA, Sharmeen L, Czarnik AW.
    Biochemistry; 1998 Oct 06; 37(40):14204-12. PubMed ID: 9760258
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
    Bohne J, Kräusslich HG.
    FEBS Lett; 2004 Apr 09; 563(1-3):113-8. PubMed ID: 15063733
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recent status of HIV-1 gene expression inhibitors.
    Baba M.
    Antiviral Res; 2006 Sep 09; 71(2-3):301-6. PubMed ID: 16488488
    [Abstract] [Full Text] [Related]

  • 11. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
    Fischer M, Joos B, Hirschel B, Bleiber G, Weber R, Günthard HF, Swiss HIV Cohort Study.
    J Infect Dis; 2004 Dec 01; 190(11):1979-88. PubMed ID: 15529263
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human immunodeficiency virus type 1 Tat-dependent activation of an arrested RNA polymerase II elongation complex.
    Liu Y, Suñé C, Garcia-Blanco MA.
    Virology; 1999 Mar 15; 255(2):337-46. PubMed ID: 10069959
    [Abstract] [Full Text] [Related]

  • 19. Human immunodeficiency virus-1 Tat protein: immunological facets of a transcriptional activator.
    Gupta S, Mitra D.
    Indian J Biochem Biophys; 2007 Oct 15; 44(5):269-75. PubMed ID: 18341200
    [Abstract] [Full Text] [Related]

  • 20. Gene therapy for HIV infection.
    Morgan RA.
    Clin Exp Immunol; 1997 Jan 15; 107 Suppl 1():41-4. PubMed ID: 9020935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.